Inspired by the natural world, our vision and mission reflect the unique value of the riparian zone, which serves as a vital interface between the river and the land to create an efficient ecosystem. Similarly, Riparian acts as an interface between our clients and technology, offering clarity amid murky government regulations and navigating the turbulent waters of the ever-changing regulatory landscape.
We help clients manage the flow of information, providing efficiency and accelerated insights through innovation.
Our suite of technology solutions, certified under ISO 27001, includes HELIX, a no-code government pricing calculation and reporting tool; ION, a Medicaid rebate adjudication application; and RNA, a commercial rebate adjudication solution. These tools streamline critical processes, reduce costs, and ensure compliance with ever-evolving regulatory requirements. Combined with our outsourcing solutions and consulting expertise, we provide strategic planning, compliance assessments, data analysis, and business system enhancements that further enhance our clients’ capabilities.
As part of the Envision Pharma Group, Riparian is supported by a global network of resources and expertise. This partnership allows us to offer best-in-class technology and AI solutions, as well as access to proprietary services through OKRA.ai, Two Labs, and 90TEN. Our commitment to data integrity and client-focused approach ensures that we deliver precise, actionable insights that drive transformative outcomes.
Alixe is the General Manager at Riparian, bringing over 23 years of experience guiding life sciences companies through government pricing, contracting, and compliance. She leads advisory and managed services across programs such as Medicaid, 340B, Medicare Part B, and VA/FSS, and drives innovation through Riparian’s proprietary GPM platform.
David brings 20+ years of experience in the life sciences where he has orchestrated the efforts of numerous multidisciplinary and cross-functional teams, and assisted organizations with financial, operational, and government exposures inherent in the complex and self-reporting nature of contractual arrangements.
